| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8684453 | European Journal of Paediatric Neurology | 2018 | 9 Pages |
Abstract
AIFM1 mutations cause childhood cerebellar ataxia, which may be partially treatable in some patients with high dose riboflavin.
Keywords
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
G. Heimer, E. Eyal, X. Zhu, E.K. Ruzzo, D. Marek-Yagel, Doron Sagiv, Y. Anikster, H. Reznik-Wolf, E. Pras, D. Oz Levi, D. Lancet, B. Ben-Zeev, A. Nissenkorn,